Sulfite can form adducts with many enzymes and nutrients in our bodies, causing massive dysfunction. Mopping up sulfite helps to reduce the feed forward activation of HIF-1alpha that leads to more expression and activity of cysteine dioxygenase, which leads to more sulfite production, and when sulfite oxidase is compromised by decreased molybdenum cofactor production or decreased heme production needed for this enzyme, this leads to the ongoing cycle of destruction. Here is a list of possible “safe” ways to mop up sulfite or work around a major block that sulfite is causing in metabolism while trying to restore sulfite oxidase activity.
Known Sulfite Mopper Uppers
(Recommendations are general guidelines and not meant to substitute for an evaluation with a health care provider regarding your individual needs. Please consult with your provider before making changes to your diet, supplements, medications, or lifestyle.)
Substance
Effects
Supplement?
Vitamin B12
Functional B12 deficiency. Sulfite binds to the cobalt center of B12. This makes binding of methyl groups and adenosyl groups impossible. There is some concern that this can occur in the digestive tract and could be a significant source of B12 deficiency.
Yes. B12 is needed for methionine salvage that helps to regenerate SAMe. SAMe is needed for making molybdenum cofactor (MoCo). Caution for individuals with sleep apnea, B12 is sequestered to the brain. Long-term intermittent hypoxia has been shown to cause cobalt toxicity of the brain. B12 can also induce the HIF-1alpha pathway which should be good, but in the presence of SUOX/MoCo deficiency this can lead to increased intestinal sulfite. Titrating up slowly may be needed. Dose:
Injections- 200 mcg hydroxocobalamin or per practitioner
Oral – 50 mcg drop (1 drop of pure encapsulations hydrox/cobalamin) every hour.
Oral – 250 mcg sublingual every 4 hours (avoid exposure to light as light can degrade B12 into cobalt)
Riboflavin
Sulfite can irreversibly bind to the ketone group of riboflavin. It has been shown to bind to flavin proteins at the N5 position on the isoalloxine ring, altering enzyme activity. It can decrease the enzyme activity of choline oxidase, glycolate oxidase, sarcosine oxidase, and d-amino oxidase.
Dose: Per individual tolerance. In migraines, dosing is 400 mg per day. However, spacing this dose out would be helpful to buffer sulfite better as riboflavin is lost quickly in urine.
AVOID taking riboflavin with molybdenum as in acidic pH of the stomach, riboflavin and molybdenum can make a complex. https://digitalcommons.usu.edu/etd/7173/
****Riboflavin has been shown to form chelates with other metals such as iron, copper, nickel, cobalt and zinc. Avoiding high doses with meals would be helpful if you struggle with iron, copper, or zinc.
Not directly. There are no betaine aldehyde supplements.
Choline intake is important due to choline oxidase can make betaine aldehyde, and overall, the choline cycle is impaired by sulfite.
Dose: 1-2 eggs per day (Low heat cooking to avoid increase methionine and cysteine conversion to H2S. Avoid taking molybdenum supplement with eggs if you suspect H2S producing SIBO.) 500 mg choline supplement of choice
Betaine supplementation can help restore betaine needed for the methionine salvage pathway. This makes SAMe, which is required in order to make choline in the body from ethanolamine.
Dose: You could try eating more betaine rich foods if you do not struggle with oxalates or gluten (wheat bran and beets)
Sulfite can form adducts with the aldehyde group on pyridoxal phosphate, but also sulfite inhibits ALDH7A1 involved in lysine metabolism, which leads to a build up of P6C and binding of P6C to pyridoxal phosphate making it inactive.
Yes. Avoid pyridoxine forms of vitamin B6 as these can lead to competition for cofactor sites and B6 toxicity symptoms.
B6 restores CBS and CSE activity. It can lead to a sudden surge in cysteine production through CBS as well as H2S production. It may lead to sudden increases in polyamine synthesis. In theory, individuals with SUOX/MoCo deficiency grow bacteria to make H2S and polyamines to compensate for lack of production of these in their bodies. Increasing B6 quickly may lead to sudden H2S toxicity and polyamine toxicity.
Dose: Start with 5 mg P5P once/day with food. Increase to 5 mg P5P every 4 hours with foods.
Dihydro-biopterin(qBH2)
Sulfite reacts with dihydropterin. This may be the cause of high urinary losses of biopterin and contribute to BH4 deficiency. BH4 is needed for healthy nitric oxide production as well as the conversion of phenylanine and tyrosine metabolism.
Unsure. There is not a good supplemental form of BH4 on the market. There are drugs to treat BH4 deficiency such as saropterin dihydrochloride.
Zoey’s metabolome showed increased urinary losses of biopterin. I was asked by the research scientist if I was supplementing with biopterin at the time of submitting urine samples. I was not. I suspect the cause of her losses of urinary biopterin are due to the damaging effects of sulfite toxicity on qBH2. Sulfite can bind to quinone dihydrobiopterin causing decreased recycling of qBH2 to BH4.
I’ve recently updated this diagram to include that choline oxidase is inhibited by sulfite. This is of major concern in sulfite toxicity due to betaine aldehyde can detoxify sulfite.
Zoey’s suddenly “cured” of hyperoxaluria as well as hyperuricemia. Is this a good thing? I think not. She has elevated glycolate levels, but low oxalate levels on her organic acid test, and her 24-hour urine oxalate levels are below the standard for someone her age as well as her urinary sulfate levels. I suspect worsening sulfite toxicity as the cause of her decreased glycolate to oxidase conversion. This isn’t a sign of improvement. It’s a sign of severe dysfunction. See the diagram below. Glycolate oxidase is inhibited by sulfite.
Zoey struggles with sleep apnea. Despite our best efforts, she rarely keeps her mask on for more than 2-3 hours per night. This means that during the night, her body increases gene transcription for HIF-1alpha in response to hypoxia. In a hypoxia state, HIF-1alpha goes to the nucleus and alters metabolism, including increasing the enzyme cysteine dioxygenase. This leads to a downstream increase in sulfite production which puts a burden on sulfite oxidase, the enzyme that metabolizes sulfite to sulfate. In addition, sleep apnea increases the activity of the enzyme xanthine oxidase. This used to be the cause of Zoey’s high uric acid levels. Xanthine oxidase uses molybdenum cofactor. Overall, sleep apnea sets the stage for Jenny Jones, PhD’s “Moco Steal” by increasing the need for more molybdenum for xanthine oxidase as well as increasing the total amount of sulfite produced by increasing CDO activity.
When the MoCo Steal from sleep apnea became extreme to the point that there wasn’t adequate molybdenum cofactor for sulfite oxidase, the sudden surge in sulfite caused a functional B6 deficiency through inhibition of ALDH7A1 resulting in a build-up of P6C. This led to decreased activity of cystathionine-beta synthase and cystathionine-gamma lyase. These two enzymes provide a significant amount of hydrogen sulfide that turns off the HIF-1alpha gene transcription. As hydrogen sulfide production decreased in Zoey’s enterocytes, she developed small intestinal bacteria overgrowth to compensate for the decrease in H2S (Greg Nigh has a theory that we grow sulfur metabolizing bacteria to provide our bodies what we need).
With the excess hydrogen sulfide in her gut, and a very oxalate restricted diet due to a history of hyperoxaluria, Zoey’s total molybdenum absorption decreased significantly due to sulfur can bind to molybdenum and when complexed with dietary copper, form a molybdenum-copper-sulfate complex that is unabsorbable. This perpetuated the problem. Over a year, her body became severely molybdenum cofactor deficient to the point that sulfite in her liver inhibited glycolate oxidase resulting in markedly high glycolate levels on her organic acids, but within range values of oxalate and below level oxalate on her 24-hour urine test.
Above you can see that Zoey’s 24-hour calcium levels have come down. She actually has decreased hypercalcemia because overall, she has improved from a vitamin A standpoint. Her serum vitamin A has dropped to 49 ug/dl which decreases osteoclasts being aggravated and breaking down bone.
Her 24 hour citrate levels have plummeted further. This is because sulfite can bind to pyruvate and prevent pyruvate metabolism to acetyl CoA. In addition, sulfite can damage all of the cofactors needed for the pyruvate dehydrogenase complex (B1, FAD, NAD, lipoic acid, and CoA). In addition, if sulfite is bound to pyruvate, it can’t be made into oxaloacetate. This leads to decreased overall levels of citrate.
Zoey’s urinary pH is quite neutral, but this is of concern to me because her blood chemistry panels over the past two years have shown hyperchloremic normal anion gap acidosis. This is consistent with renal tubular acidosis OR the actions of glutamate/s-sulfocysteine on NMDA in the kidney and activation of the sodium exchanger (ENaC). I have seen this hyperchloremic normal anion gap acidosis in many people who have suspected sulfite oxidase/moco deficiency. Activation of the ENaC results in uptake of sodium and chloride and wasting of potassium (sodium and chloride in urine below the reference range). Zoey’s urinary potassium is quite low, but her blood potassium is also low on blood draws. She has become potassium deficient and so her body is attempting to retain as much potassium as possible. During this 24-hour urine test she was getting 1000 mg of potassium citrate and 350 mg of magnesium citrate.
Zoey’s low phosphorous level is of a concern due to it may indicate intestinal malabsorption. She has a high risk for Crohn’s disease due to MBD5 deletion can increase the mRNA expression of FOLH1, that is higher in individuals with Crohn’s. The drop in her urinary sulfate below normal is consistent with sulfite oxidase deficiency. I suspect her levels are even lower because I give her magnesium sulfate foot baths every other day. The drop in her creatinine and urinary urea nitrogen indicated struggles with creatinine production (functional B6 deficiency and/or methylation decreased due to sulfite binding to B12, inhibiting betaine production, and oxidative stress damaging 5-methylfolate). Her low urinary urea nitrogen indicates a probable decrease in ornithine production needed for running the urea cycle as this is a byproduct of creatine production as well as can be made from proline but requires vitamin B6.
As you can see above, overall, Zoey is struggling with sulfite toxicity. I think that since birth (she had hypoxia in the womb due to placental abruption) Zoey has been stuck in the HIF-1alpha pathway to varying degrees her whole life. We are working on a therapeutic plan to deal with this constant, chronic uptick in sulfite production as well as strategic avoidance of sulfur foods at the time of taking mozyme forte.
References:
Ghanem, Mahmoud. On the mechanistic roles of the protein positive charge close to the N(1)flavin locus in choline oxidase.
Meier, Sebastian & Solodovnikova, Natalia & Jensen, Pernille & Wendland, Jürgen. (2012). Sulfite Action in Glycolytic Inhibition: In Vivo Real-Time Observation by Hyperpolarized 13C NMR Spectroscopy. Chembiochem : a European journal of chemical biology. 13. 2265-9. 10.1002/cbic.201200450.
But what is vitamin A toxicity? Do we all have full livers? No. 30% of us might have full livers.
Some of us have vitamin A dysregulation which is caused by poor metabolism (low NAD state) and/or effluxing vitamin A back into the blood due to high intracellular calcium (SSC activation of NMDA, EMF activation of calcium channels, Magnesium deficiency causes STRA6 to prefer to stay on and efflux vA out into blood). High blood vitamin A levels aren’t good for sure, but they are also a squeaking wheel for major metabolic issues.
If you have HIGH retinol and LOW uric acid you have a molybdenum cofactor deficiency, and this could merely be inadequate molybdenum intake. If you take molybdenum, but still have low uric acid and high retinol, then you are struggling with making MoCo. Come join the Moco Steal group. We need to be making MoCo to have back up enzymes for metabolizing retinol and retinaldehyde. It requires several cofactors to be made.
Does vitamin A, in the form of retinol, trigger us to make uric acid? No. I would say that retinol is associated with high uric acid first due to enzyme competition. If XOR family enzymes are busy dealing with other substrates on the left of the diagram below (caffeine, high dose niacin, purines, aldehydes, etc), then it can’t play back up for ALDH enzymes metabolizing retinol and retinaldehyde.
We need MoCo for SUOX which metabolizes sulfite. Sulfite destroys thiamine. Sulfite toxicity will cause the pentose phosphate shunt pathway to prefer to send RP5 towards uric acid. If sulfite toxicity is very high it will stop the pentose phosphate shunt pathway all together by inhibiting the first enzyme, glucose-6-phosphate dehydrogenase. Having low uric acid could mean severe sulfite toxicity and severe MoCo deficiency. Having high uric acid could mean low B1 status.
B1 Deficiency Causing Increase Purine Synthesis. Another possibility is that the underlying issue is excessive shuttling or RP5 towards purine synthesis in the setting of thiamine deficiency (needed for TKT activity) due to sulfite toxicity. This sulfite toxicity could have been originally caused by high dose vitamin A causing a MoCo Steal. Sulfite immediately destroys B1, but the body will do it’s best to mop up sulfite (binds to B12, betaine aldehyde, cysteine). However, B1 deficiency can be caused by other factors too including excessive caffeine intake, too much sushi, Lasix therapy, poor oral intake, etc. B1 deficiency causes more RP5 resulting in more PRPP and the production of more uric acid. This pulls XOR enzymes away from retinol and retinaldehyde metabolism.
Does a ZERO vitamin A diet solve the uric acid problem? No. In fact, it could make it worse. The adaptative immune system uses vitamin A in the form of retinoic acid (see diagram). We do need physiological levels of retinoic acid to prevent XOR dominance happening where the innate immune system attacks bacteria and viruses with H2O2 made using Xanthine Oxidase instead of recruiting additional immune cells.
Consuming 25-50% of the RDA of vitamin A plus adding a lower dose of niacin (35 mg) at those meals seems to help my family.
****************************************
I’m a dietitian, not a doctor. I am probably not your dietitian. Please consult with a personal healthcare provider prior to making changes to you diet, medications, supplements, or lifestyle. This is written only to inform, and not to diagnose or treat a condition. This blog does not replace an evaluation by a medical professional. – Meredith Arthur, MS, RD, LD
Jenny Jones PhD and I have a hypothesis paper explaining how a MoCo Steal can lead to a Sulfite Trap involving the excess production of s-sulfocysteine (SSC), an NMDA agonist on steroids, and excess sulfite production. The MoCo Steal was a term adopted by Jenny as she liked your phrase, “NADPH steal” and felt her cascade into seizure disorder was caused by a shift of molybdenum cofactor away from SUOX towards AOX due to inadequate NAD for working ALDH enzymes as well as other blocks to this including high dose vitamin C. My daughter Zoey has MBD5 deletion which leads to increased expression of Mocosulfurase which may have caused her preferences to make more xanthine oxidase and aldehyde oxidase and less sulfite oxidase. As we continued to research, we found that the sulfite toxicity can be caused by the interaction of the immune system and hypoxia pathway, hypoxia-inducible factor 1 alpha which increases the expression of CDO to help with s-sulfenylation during oxidative stress as a mechanism by which to protect cells, but that instead of this metabolic switch ending in sulfate, individuals struggling with the MoCo Steal, end up in a Sulfite Trap.
Once someone is not working SUOX properly, there is a feed-forward mechanism because SSC’s robust effect on NMDA causes intracellular calcium overload leading to activation of calpain protease with subsequent degradation of gephyrin. Gephyrin is needed to add molybdenum to the molybdenum cofactor (MoCo).
Damaging effects of SSC due to excess calcium influx
loss of gephyrin and ability to incorporate molybdenum into MPT
loss of gephyrin that holds GABA receptors in place resulting in loss of functioning GABA synapses and subsequent imbalance of glutamate to GABA with effects downstream neurological effects
inhibition of PDHC and lactic acidosis
inhibition of glutamate aspartate transporter (GLAST) causing loss of glutamate uptake in neurons resulting in low brain energy levels
potassium and sodium wasting via over-excitation of NMDA in the kidneys with subsequent loss of the ability to uptake bicarbonate, increased H+ ions, and retention of chloride causing a non-anion gap hyperchloremic acidosis
Sulfites direct damaging effects include:
need for metabolizing by cytochrome C using oxygen leading to loss of mitochondrial oxygen and production of sulfite radicals. The oxidative stress triggers HIF-1alpha which increases CDO and leads to more sulfite due to the loss of SUOX activity
inhibition of ALDH7A1 with subsequent altered lysine metabolism resulting in a build-up of P6C and functional B6 deficiency
cleavage of the methylene bridge of thiamine causing thiamine deficiency
binding to B12 as sulfito-cobalamin causing a functional B12 deficiency and loss of MUT causing inadequate succinyl CoA and slowed heme synthesis
inhibiting glutamate dehydrogenase in neurons results in decreased alpha-ketoglutarate, diminished movement of the TCA cycle, decreased mitochondrial membrane potential, and decreased ATP synthesis.
inhibiting glutamate dehydrogenase in other cells leads to similar effects, but also loss of alpha-ketoglutarate to act as an antioxidant during oxidative stress
damage to lysosomes causing them to leak cyanide which ties up MPST in the production of thiocyanate. Thiocyanate causes loss of uptake of iodine into the thyroid gland and hypothyroidism
Functional B6 deficiency from ALDH7A1 inhibition causes:
inability to complete de novo NAD production via the kynurenine pathway
loss of CBS and CSE activity
inability to start heme synthesis due to ALAS requires B6 (or minimal ability due to triage flux of B6 towards important cellular needs)
decreased serine hydroxy methyltransferase (SHMT) activity leading to decreased glycine production from serine, but glycine supplements cause reactions due to acting as co-agonists to NMDA
severe cases lead to a lack of histamine production (resolution of histamine intolerance but at the same time severe neurological presentation with loss of motor coordination)
less severe cases, decreased ability to metabolize histamine with ALDH7A1 side of histamine metabolism leading to increased burden on HNMT
decreased glutamate to GABA conversion
Sulfite binds to cystine to make SSC which can cause cystine deficiency. This could be restored by SSC being taken up by cells and metabolized using glutathione, but the shift towards the hypoxia pathway causes more cysteine to be shuttled towards CDO and overall there is a glutathione deficiency. Due to oxidative stress, cysteine is also shuttled towards CDO to produce cysteine sulfenic acid to protect enzymes during oxidative stress so that when it resolves the cell can resume function.
Cysteine deficiency then causes…
loss of lipoic acid, CoA, and FAD and FMN (sulfite binds to the N-5 catalytic site of B2 causing flavin containing enzymes to be nonfunctional).
overactivation of NRF2 activation leading to keratinization
vitiligo due to failure to prevent apoptosis of melanocytes and due to sulfite can inhibit glycolate oxidase. Glycolate inhibits tyrosine hydroxylase needed to produce melanin.
(CoQ10 needs cysteine for production – prenylation- but this seems conserved due to needing large amounts of ubiquinol for degradation of HIF-1apha)
Sulfite toxicity and cysteine deficiency collide at the crossroads of transsulfuration and the HIF-1alpha pathway.
I’m a dietitian, not a doctor. This isn’t medical advice. Talk with your healthcare provider before making changes to your diet, supplements, medication, or lifestyle.
For the past year or so Jenny Jones and I have been discussing her MoCo Steal Theory. Her theory is that due to blocks in NAD recycling and various other blocks at ALDH, she had to use more of the low affinity, high-capacity enzyme for vitamin A metabolism, aldehyde oxidase (AOX). This caused a stealing of molybdenum cofactor towards AOX and away from sulfite oxidase (SO or SUOX) leading to a loss of sulfite oxidase activity. Sulfite then caused the functional B6 deficiency that she and I collaborated on where the moonlighting enzyme ALDH7A1 was completely inhibited by sulfite causing a sort of late-onset pyridoxine-dependent epilepsy from a functional B6 deficiency.
.
Controlling glutamate is important through dietary interventions to reduce free glutamate if you struggle with seizures or migraines, but there is a sneaky glutamate-like compound being made in our bodies every day called s-sulfocysteine (SSC). It’s the dipeptide cystine bound to free sulfite. Chris Masterjohn talks of how we all have this in varying amounts.
.
Jenny, Andrew Baird, Michelle Harris, and I have been discussing that vitamin A “toxicity” is actually vitamin A “dysregulation” and overall isn’t a poisoning from retinoic acid because most of us aren’t even getting to the point of making retinoic acid due to the massive dysfunction caused by sulfite toxicity.
.
After many months of research, I have concluded that Jenny’s MoCo Steal may have happened to some of my clients in the past including my daughter. However, I noticed that they had gone beyond a MoCo Steal and had fallen into a Sulfite Trap because when we can’t metabolize sulfite, we make s-sulfocysteine (SSC) and have excess free sulfite causing damage to our mitochondria leading to a feedforward cycle of destruction that meets at the crossroads of transsulfuration and the immune and hypoxia response pathway, hypoxia-inducible factor-1 alpha (HIF-1alpha).
.
Regarding vitamin A metabolism. SSC over-activates NMDA receptors on many cells in the bodycausing large increases in intracellular calcium which then causes retinol to efflux out of cells back onto RPB4. This is the high serum A that we experience. It’s a cellular deficiency of vitamin A, but blood toxicity.
.
Although high liver vitamin A stores are still possible, I think that high serum vitamin A is the squeaking wheel on a very broken race car called Acquired Sulfite Oxidase Deficiency. This leads to intolerance to vitamin A-rich foods. The thesis linked to in the description section of the video will explain dry skin, collagen loss, and poor glucuronidation, but this is not covered in this preliminary video below which only explains how we get trapped in this pathway.
But the damage doesn’t stop at vitamin A intolerance.
Both sulfite in the mitochondria and SSC cause an increase in the activity of cysteine dioxygenase (CDO) through the activation of HIF-1alpha. Upregulation of CDO leads to shutdown of the cells through s-sulfenylation with cysteine sulfenic acid. This is a life-saving effort to protect enzymes from oxidative stress so that when the cell turns back on, the cell won’t have to start all over again. The bad part is, that leftover cysteine sulfenic acid is metabolized to sulfite and should be further metabolized to the beautiful, life-saving sulfate which is used for Phase II liver detox. Instead, we make more sulfite which leads to more mitochondrial damage as well as more SSC which causes more increases in CDO and more sulfite. It’s a trap.
.
SSC itself causes alterations in metabolism that cause the loss of the ability to make MoCo because it leads to loss of gephyrin needed to add molybdenum to molybdopterin and eventually loss of the ability to make the SUOX enzyme as well for some people. Cells outside of the central nervous system express NMDA receptors, which can respond to SSC, including hepatocytes, a major site of sulfite oxidase activity.
.
This pathway leads to cysteine deficiency from tying up cystine in the blood with sulfite. This eventually leads to the inability to make FAD due to FAD synthase needs the cofactor molybdopterin (MPT) which requires a sulfur group from cysteine. MPT is NOT molybdenum. It’s the step before molybdenum. Taking molybdenum is not a way to restore FAD synthesis. It’s not involved in that reaction. Just MPT, the empty shell of MoCo, for lack of better terms, is what is needed for making FAD.
.
And the damage to other cofactors and pathways is evident. Anything that requires cysteine will be decreased such as lipoic acid, coenzyme A, activation of NRF2, and production of CoQ10 (although I mostly see this pathway conserved, if not high on Genova testing, because people need CoQ10 for the HIF-1alpha pathway, but they aren’t using it in their mitochondria at SQR as the mitochondria are shut down trying to repair the damage from sulfite and I doubt that CBS and CSE are working much at all due to functional B6 deficiency from sulfite inhibiting ALDH7A1).
.
Activation of NMDA receptors in the kidneys causes potassium wasting and sodium wasting, but chloride retention, and inability to uptake bicarbonate from urine lead to non-anion gap acidosis which is often missed by doctors. It can also cause hyperaldosteronism and hypertension. I suspect that anyone requiring high dose thiamine for life with high dose potassium intake is a maker of excessive amounts of SSC. Free sulfite is probably the cause of many individuals’ thiamine deficiencies as sulfite cleaves thiamine at the methylene bridge essentially destroying it.
.
In the brain, SSC over-activates NMDA receptors on GABAergic synapses leading to excessive calcium influx into cells, loss of gephyrin needed to hold GABA receptors in place, and destruction of the synapses. This leads to a high excitatory state with low inhibition and can cause seizures as well as anxiety, pain, bowel dysmotility, tremors, and dysautonomia.
.So…I humbly ask for you to consider this hypothesis that I’m living out in real time. I am not trying to be a savior. I’m just sharing an awful experience and showing my love for my fellow humanity by putting this out there. I am currently stuck in the sulfite trap with my daughter, Zoey. I got here when I took garlic and NAC to lower my blood pressure and then added in rolled oats. It was a snowball effect leading to severe sulfite toxicity. I think I have a way of escaping, but I am tired.
Because of the underlying sympathetic surges that I have right now, negative comments will harm me physically. Please refrain from making negative comments about Jenny and my work until you have thoroughly investigated it and proven it wrong. I would like for all the great minds out there in our world to take over and help find a solution to this problem if they feel that my hypothesis is valid. I think I have a few good ideas, but I do not know everything. I need YOU…smart people. Help save my brain and everyone else’s, please.
,
If I am wrong on this HYPOTHESIS. I may end up on 20 medications to control the massive symptoms that I have. However, currently, Benadryl is helping. This is not a medication recommendation for anyone…you MUST go to your doctor or practitioner with this idea. This is a dangerous trap.
Benadryl blocks NMDA receptors nicely and is reducing all my symptoms, but I’m still not fixed because when I stop the Benadryl, I fall back into horrible symptoms such as anxiety, tachycardia, insomnia, high blood pressure (some have low blood pressure), pain, internal tremors, burning sensation all over my body, and more. Only time will tell if blocking NMDA digs me out of the trap. I have a few other ideas as well in the collaborative thesis paper that Jenny and I worked on.
If you aren’t having a hypertensive crisis, there is another way out. I had a client heal with a few small changes. She still has migraines and histamine reactions, but her neurological symptoms have improved immensely. More on that soon.
CAUTION!!!!!!
Do not try to get out of this trap alone!!! Blocking NMDA restarts metabolism and some things might happen that aren’t pleasant. If you over block NMDA and then remove the block, you could have a SEIZURE. You must be aware of this risk. PLEASE WORK WITH YOUR PRACTITIONER.
Do not add NAC if you think you are stuck in this pathway until you get with a practitioner to find some way to block your NMDA receptor UNDER the SUPERVISION OF A HEALTHCARE PRACTITIONER but titrate it for your own needs and monitor your electrolytes and labs. Blocking NMDA receptors restarts metabolism, but we don’t have all the co-factors ready and I’m worried that fragile people need close monitoring. There is a risk that you don’t have all the cofactors for finishing the conversion from pyruvate to acetyl CoA. I think that this can lead to mitochondrial aldehyde toxicity. I sent a message to Dr Marrs about this. She plans to look at what I wrote on Monday.
I think whenever we’re using an NMDA blocker, UNDER SUPERVISION OF A HEALTHCARE PRACTITIONER we have to do a very gentle diet where we consistently eat only a small amount of carbohydrates every 2 to 2.5 hours so that we don’t go into full-blown lactic acidosis because lactic acidosis will get us stuck in the same pathway. Lactic acidosis could lead to the same increase in the CDO activity that I described in the video. So, it would be a low carbohydrate diet but not carbohydrate-free because to avoid gluconeogenesis as making glucose uses GTP. GTP is needed for making MPT and molybdenum cofactor.
Here is a link to the video. Here is a link to a HYPOTHESISpaper.
how I think that vitamin A metabolism issues result in SIBO or SIFO. I hope to have some diagrams at some point, but here is my general idea of what is happening. I think the development of SIBO/SIFO is multifactorial, but I will explain it from a vitamin A point of view.
In general vitamin A is needed at ***physiological levels*** in the gut to fight both candida and also bacteria. Zoey had high serum A which the GI doctor, me (dietitian), and the GI dietitian assumed was an accumulation of toxic amounts of vitamin A from some unknown alteration in enzyme activity perhaps. She is very unique. So, the solution that we all agreed on was ZERO vitamin A including no eggs (I didn’t know that Dr. Smith or Grant G existed at that time, so this was all on my own initiative).
When she went low vitamin A, but had high serum A, all parties assumed that she would have plenty of vitamin A to use in her GI tract. What we didn’t account for is that although vitamin A bound to RBP4 can get back to the GI tract, it still has to be taken up and stored in cellular retinol binding protein. Also, it has to become retinoic acid in those immune cells that take it up.
****The reasons why I think dietary vitamin A has helped her is because the enterocyte can metabolize vitamin A into retinoic acid using ALDH1A1. This retinoic acid can then transfuse into the blood and gut associated lymphoid tissue to be used by the immune cells. It bypasses the need for retention of retinol inside of cells of the immune system****
Zoey was struggling with both activities it seems. First, she struggles with calcium dysregulation. Zoey struggles with a mild form of renal tubular acidosis due to a down regulated mRNA expression for a bicarbonate transporter, but also, she has an underlying issue with sleep apnea which induces a pathway called hypoxia inducible factor 1 alpha (HIF-1alpha). This pathway causes lactic acidosis. The acidosis causes loss of magnesium in the urine. Magnesium is crucial for controlling calcium levels in cells by being part of the EF hand of a calcium binding molecule calmodulin that regulates cellular dynamics. Calmodulin controls the STRA6 pore that decides on whether vitamin A stays in the cell or leaves the cell. When cellular calcium is high, vitamin A is preferentially effluxed back into the blood onto RPB4 leaving the cell void of retinol. This includes immune cells as macrophages, B-cell, and mature dendritic cells all contain STRA6.
In macrophages, just binding of RPB4 to TLR4 induces an inflammatory response. The increase in NF-KB that happens when RPB4 docs with macrophages upregulates HIF-1alpha gene transcription. (LPS can also induce the NF-KB pathway in macrophages leading to HIF-1alph activation.) This should help increase the ability of immune cells to fight fungal infections. However, because of calcium dysregulation, retinol doesn’t stay in the cells to be able to make retinoic acid which upregulates dectin-1 receptor production. Neutrophils and dendritic cells also respond to retinoic acid by increasing the dectin-1 receptor.
So, you may have an increase in HIF-1alpha pathway (which by the way causes lactic acidosis which worsens magnesium losses and increases ionized calcium as well as increases calcium uptake into cells), but a decreased recognition of candida. Candida is recognized by the immune system specifically through the fact that it has beta-glucan on its cell wall. The immune system recognizes beta-glucan using the dectin-1 receptor. If dectin-1 expression is low, this can result in decreased ability to fight fungus despite having HIF-1alpha turned on. I don’t think the fight is completely stopped though. It’s just less efficient. Retinoic acid upregulates dectin-1 receptor. It isn’t necessarily absent when retinoic acid is low. However, in B-lymphocytes, lack of retinoic means decreased secretory IgA for binding to LPS. Less retinoic acid also means poor conversion of monocytes to macrophages and failure to recruit more white blood cells from the blood to the sight of infection in the gut due to less cytokine production. When LPS increase, it also triggers macrophages to make NF-KB which can increase HIF-1alpha transcription and lead to the HIF-1alpha pathway. The only gut bug that can dampen this response is enterohemorrhagic E. coli. And that is NOT a good thing. Either having EHEC or having poor retinoic acid production will cause candida to flair badly. This is what leads to SIFO I believe.
Lack of sulfate causing damage to immune cells in the gut because of anhydroretinol toxicity?
Another factor for Zoey that I see happening in many people is the lack of sulfate for back up alcohol metabolism in the gut. Specifically, b-lymphocytes have been shown to produce anhydroretinol (alcohol + acetic acid at human pH = anhydroretinol). Excess alcohol in the gut can result in death of B-lymphocytes which means less secretory IgA and more risk for LPS entering the body.
This lack of sulfate was coming from two issues. 1: oxalate (uses same transporter as sulfate) 2. Molybdenum deficiency (needed for SUOX enzyme to turn sulfite into sulfate). The oxalate issue was because a well meaning dietitian’s handout (kidney dietitian .org) has plantain as low oxalate when it is not. The molybdenum deficiency was caused by high amounts of vitamin A return to the liver I think and when vitamin A is high, the body using AOX for metabolism. Also, though, due to chronic hypoxia, Zoey had been stuck in the HIF-1alpha pathway that is the same pathway used to fight candida. In this pathway the enzyme CDO is upregulated which increases the need for SUOX activity. However, on top of that sleep apnea increase xanthine oxidase activity which also needs molybdenum. And then to add to that mess, Zoey has upregulated mocosulfurase mRNA expression which means she preferentially makes AOX and XO over SUOX. Phew. So in general she became very slow at SUOX, but needed more SUOX due to HIF-1alpha upregulation of CDO. (Jenny Jones, PhD and I have done significant work on this Moco Steal pathway. I will share more about it soon.)
Here is where SIBO comes in…
One of the things that HIF-1alpha does when fighting candida is increase the gene transcription for heme oxygenase 2 (HO-2). HO increases carbon monoxide levels which leads to a down regulation of CBS enzyme activity. This means LESS hydrogen sulfide. So, to compensate, the body might allow H2S producing bacteria to grow to help the body out with the lack of H2S available due to high RBP4 or LPS triggering NF-KB which increase HIf-1alpha. (Something to think about is that high serum A is a sign of high RBP4, but low serum A is NOT a sign of low RBP4 as RBP4 doesn’t have to be carrying vitamin A. It can carry palmitate and also anhydroretinol. Vitamin A can be low on tests and there still be an issue with RBP4).
This theory of growing sulfur metabolizing bacteria is actually a Greg Nigh theory of SIBO, but the process of what is causing us to not make enough at times is something I think goes along with vitamin A dysregulation. I love Greg’s theory, and it fits with what Zoey experienced with vitamin A dysregulation. It fits 100% with her developing SIBO when going very low vitamin A.
Other inducers of HIF-1alph besides hypoxia and candida include probably spike protein, nicotine, and beta-glucan.
Can HIF-1alpha pathway cause Vitamin A dysregulation and high serum vitamin A levels? Yes. I think it can.
Now back to that upregulated HO-2 enzyme from the HIF-1alpha pathway. As CO levels increase, O2 levels in the tissue drop. This eventually causes slowing of HO-2, and so then CBS turns back on because there is less carbon monoxide. When this surge of H2S happens, potassium leaving the cell is blocked. This causes an uptake of calcium and high intracellular calcium levels if the PMCA pump is not working well (calmodulin dependent and also needs magnesium on the EF hand). This is when I think there is even more vitamin A dysregulation as vitamin A effluxes back out of cells and worsens the whole situation especially for immune cells in the gut that require retinoic acid to make secretory IgA.
So there are many places in this path to think “what comes first, the chicken or the egg”. Is it high serum A that causes all the dysfunction? Is it the poor production of retinoic acid in the gut? Is it hypoxia alone inducing the HIF-1alpha pathway? Is it sneaky anhydroretinol? Maybe using a cod liver oil brand with a bunch of anhydroretinol?
What has helped for Zoey?
Electrolyte balance. This is difficult to translate to all people. I suggest tracking your intakes in Cronometer and making sure you get at least 2400 mg sodium (need the Na-Ca exchange transporter working). Goal for potassium is what your RDA is when you put in your stats. Then on magnesium, if you are in acidosis, making sure to get twice the RDA perhaps. I don’t go higher because too much magnesium can act like a beta blocker and slow down the gut more. I typically don’t push electrolytes in doses. I add them to 2 liters of water and give over the course of one day. I use a combination of citrate, gluconate, and bicarbonate. I sort of just have found what works with her. I keep the bicarbonate at no more than 250 mg of potassium bicarbonate per day because going higher seems to make candida grow. Plus, huge shifts in bicarbs sends her reeling because even though she has RTA most of her acidosis seems to be lactic acidosis or glycolate poisoning from hypoxia.
Zoey also gets 250 to 500 mcg of B12 per day added to the 2 liters of water. She gets 250 to 350 mg betaine as well. Both of these help with the iNOS causing high nitric oxide and a functional B6 deficiency
She gets 15 mg of nicotinamide riboside at each meal that has 25% of the daily value of vitamin A (usually 1 to 2 meals per day – goal is 50% daily value). We don’t use nicotinic acid because it causes calcium dysregulation to worsen. We don’t do high dose because it puts burden on AOX which means more of MoCo steal and worsening sulfite issues. I don’t recommend any niacinamide, nicotinic acid, or nicotinamide riboside to anyone who is a carrier of enterohemorrhagic E. coli as it has been shown to encourage the adherence of this E. coli to the gut. I am thinking about switching to NMN, actually.
She gets 100 mg ginger extract at each meal with vitamin A to increase the ALDH1A1 enzyme activity in the gut, so she makes retinoic acid. She is thankful to have a g-tube for this reason! Haha (yes, she does eat orally, but gets liquids through a stomach tube)
We use Orthomolecular Motility Pro as a prokinetic agent. It works well. I give it only once a day on an empty stomach.
We keep fat intake to 10-15 grams per meal maximum to lower LPS entrance in chylomicrons. This also helps to decrease TMAO production by bacteria in the gut. The higher the fat, the more TMAO. That leads to lower bile acid pools and worsening constipation. Constipation is not good for SIBO and SIFO.
What if periodic “oxalate dumping”, intolerance to dietary oxalate, and subsequent low NAD/NADH ratio leading to hypervitaminosis A (retinol/retinaldehyde toxicity with simultaneous retinoic acid deficiency) is caused by a block at pyruvate dehydrogenase complex (PDHC) due to sleep apnea or due to the immune system activation during a fight against fungal infections or bacterial infections? What if lack of oxalobacter formigenes (breaks down oxalate) isn’t the only issue?What if gut dysbiosis triggers our own body to produce oxalic acid?
***I’m a dietitian and not a doctor. This post is written for informational purposes only and not meant as medical advice. Any therapeutic suggestions made in this post should be discussed with your own personal health care provider prior to making any changes to your diet, nutrition, supplements, or lifestyle.***
On August 6th, 2023 I wrote this article Oxalate: A Potential Contributor to Hypervitaminosis A – Hormones Matter for hormone matter regarding a hypothesis that hyperoxaluria and high dietary oxalate contributes to hypervitaminosis A by altering cellular NAD to NADH ratio contributing to a high retinol state and a low retinoic acid state. I felt like dietary oxalate was a huge component to Zoey’s chronic hyperoxaluria and do believe that plantain flour, recommended by a dietitian who is an expert in kidney disease, was the cause of Zoey’s unfortunate oxalate poisoning. However, what if the reason that Zoey is unable to tolerate dietary oxalate is actually that she, herself, is an over producer of oxalate in her body depending on her oxygen levels or immune function?
Hypothesis: The cause of new onset idiopathic hyperoxaluria and glycolate toxicity may actually be overactivation of HIF-1alpha due to fighting bacteria, fungus, hypoxic conditions, and/or sleep apnea.
My daughter Zoey is unable to tolerate more than 50 mg of oxalate a day and is sick every afternoon with headache and nausea. Why? Although she lacks the genetics for primary hyperoxaluria, she periodically becomes an oxalate producer that at first seemed random. She also struggles with high glycolate levels on her organic acid test despite doing all the right things recommended for resolution of glycolate toxicity. Looking back on her twelve years of life, I have realized that her bouts of high urinary oxalate levels and horrible headaches weren’t random at all, but occurred when she was fighting a bacterial or fungal infection or when she was non-compliant with her CPAP mask for sleep apnea.
Recently this all worsened, and many of my side clients were experiencing similar issues. This prompted me to find an answer to this mystery. I asked myself, “What if hyperoxaluria, despite consuming a low oxalate diet, and having no genetic aberrations to cause hyperoxaluria, isn’t the product of bad glycine metabolism? What if it is the after effect or the ongoing effect of the activation of HIF-1alpha, a factor that is made in the body whenever it is fighting fungus or bacteria or when experiencing hypoxia?”
HIF-1alpha causes a block at pyruvate dehydrogenase complex (PDHC). After extensive research and comparing of organic acid test results among those who share them with me, I believe that a block at PDHC by HIF-1alpha may be the number one contributing factor to production of endogenous oxalate in the setting of B6 sufficiency, and this block at PDHC can account for a paradoxical reaction to B6 supplementation increasing oxalate formation. In fact, when people are functionally or marginally deficient to severely deficient in B6 I propose that they will make less oxalate while producing more glycolate, which unfortunately poisons them if the kidneys cannot keep up with excretion of this metabolite.
HOW DOES A BUILD UP OF PYRUVATE CAUSE HYPEROXALURIA?
Pyruvate in excess that is unable to escape by six different metabolic pathways (explained further below) is shuttled to the peroxisome and combines with serine via a reaction metabolized by alanine glyoxylate transferase (AGT) to hydroxypyruvate (Figure 1). Hydroxypyruvate is then metabolized by Glyoxylate Reductase/Hydroxypyruvate Reductase (GR/HPR) to D-glycerate and L-glycerate. This enzyme is the same enzyme that metabolizes glyoxylate to glycolate. If this enzyme is tied up in hydroxypyruvate metabolism due to excess pyruvate build up, it may not metabolize glyoxylate to glycolate. The end result is more glyoxylate is made into oxalate via the enzyme lactate dehydrogenase (LDH). This should have feedback inhibition on LDH and stop the formation of further oxalates. However, if someone is fighting a bacterial or fungal infection, or even has excessive inflammatory macrophages produces excess NF-KB such as in the acute phase response to illness, HIF-1alpha increases. HIF-1alpha, in turn, upregulates the enzyme LDHA and so feedback inhibition by oxalate is overridden by the sheer abundance of lactate dehydrogenase available. LDHA is the same enzyme isoenzyme involved in glyoxylate to oxalate conversion and is actually a therapeutic target for individuals with primary hyperoxaluria. See Figure 1 for a pictorial demonstration of this pathway and a summary of inhibitors of PDHC.
When I added B6 to my own family members regimen to stop oxalate production, they only worsened. Of course, B6 is necessary for many reactions in the body, but what if the worsening of oxalate formation from adding B6 is due to supporting the already overworking AGT enzyme and the tying up of the moonlighting GR/HPR enzyme in dealing with hydroxypyruvate? Perhaps dealing with the block in pyruvate metabolism is the better way to solve the problem?
HYPEROXALURIA DUE TO EXTENSION OF IMMUNE FUNCTION
Whether fighting a bacterial or fungal infection, HIF-1alpha gets involved in redirecting glucose metabolism to provide energy for T-cells of the immune system via alteration of metabolism including inhibition of PHDC. In the research area myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) community, Dr. Rob Phair working with Dr. Ron Davis have a theory that ME/CFS occurs when cells other than the immune system take on an immune pathway. These cells adopt the itaconate pathway. Dr. Fair’s Itaconate Pathway theory for ME/CFS makes sense from a clinical standpoint as more and more people are experiencing altered metabolism.
If cells outside of the immune system are now taking on immune function, and there is an increase in HIF-1alpha orchestrating a multi-cellular response in the liver and kidneys, then it’s possible that HIF-1alpha pathway itself becomes a source of excess pyruvate that can contribute to hydroxypyruvate competition for GR/HRP. In addition, HIF-1alpha itself is tagged with hydroxyproline for degradation by proteasomes, and hydroxyproline can be a source of oxalate formation in PH type 1, 2 and 3 according to this in vivo human study. Overall, it appears that the adoption of a HIF-1alpha change in energy metabolism could be a major contributor to hyperoxaluria. My own daughter has experienced hyperoxaluria without having any genetic discrepancies as a contributing factor. What she does have, though, is chronic candida, and chronic bacterial infections, as well as sleep apnea as contributors to overactivation of HIF-1alpha.
WHAT ACTUALLY IS BLOCKING PYRUVATE METABOLISM?
HIF-1alpha itself has been shown to block PDHC leading to a buildup of pyruvate. However, it isn’t the only cause of a block at PDHC. In figure 1, I list the possible blocks of PDHC. Of course, thiamine deficiency is an obvious cause of loss of PDHC function and Dr. Londsdale and Dr. Marrs are the authorities on the downstream effects of thiamine deficiency. Yet, there are some people not responding to thiamine supplementation. These are the outliers. These are a few of the people in my family and some of my clients who do not improve with high dose thiamine, and possibly some of the people that I interact with online in forums who aren’t responding to thiamine supplementation. It may be that although thiamine can definitely fix the PDHC complex, along with other cofactors, it may or may not fix a metabolic block caused by the immune system or hypoxia. One question to explore would be, “If thiamine over-rides a metabolic block produced by the immune system, will bacteria and fungus be successfully eradicated?”
The lack of improvement with supplemental thiamine may be because HIF-1alpha causes a block at the enzyme pyruvate dehydrogenase complex (PDHC) leading to a buildup of pyruvate that must be shuttled somewhere. Figure 2, adapted from the six metabolic fates of pyruvate shows various ways that the cell deals with excess pyruvate. The seventh possible place for pyruvate to be shuttled is the peroxisome to form hydroxypyruvate as I show in Figure 1.
So, it’s possible that as long as there aren’t any blocks in enzyme #1-6 shown in figure one, that a person will not actually push pyruvate to the peroxisome to make hydroxypyruvate despite a block at PDHC for various reasons. Hyperoxaluria from a block at PHDC only becomes a problem when these other escape pathways for pyruvate are shut down, or when lactate is unable to be cleared from the body due to uremia (such as that occurs in chronic kidney disease or an obstructed ureter that occurs in kidney stone formation).
DIVERSION OF PYRUVATE AWAY FROM THE PEROXISOME
I think the goal of someone with hyperoxaluria who is stuck in a chronic state of fighting infection or struggling with hypoxia, is to concentrate on the six metabolic fates of pyruvate below. In figure 3, I have summarized some of the blocks of the enzymes of the TCA cycle that can lead to inhibition of pyruvate carboxylase and citrate synthase. Feel free to discuss these blocks with your own health care provider as I am unaware of your medical history. I hope to make a few short videos about how to get around each block in the pathways below in the future.
ORGANIC ACID TEST PROOF THAT BLOCKS AT PDHC CAUSE HYPEROXALURIA
Although I am currently taking a break from full time practice to care for my daughter, I often glance at organic acid tests for people who contact me and help them on the side, especially when someone has lost all hope. I have seen this trend of hyperoxaluria or high glycolate many times over in organic acid testing when someone is struggling with fighting a bacterial or fungal infection and has had to mount what seems to be a whole-body response. Here is a link to a recent YouTube video I have made that has screenshots of organic acid testing and explanations of how these results fit the picture of alterations in pyruvate metabolism contributing to hyperoxaluria. The video includes a little bit of theory on a sneaky metabolite of vitamin A, anhydroretinol, that could be causing some people to develop thiamine deficiency and also immune dysfunction leading to chronic infections that trigger chronic activation of HIF-1alpha.
HIF-1ALPHA DEGRADATION IN NORMOXIA CAUSES HYPEROXALURIA AND GLYCOLATE POISONING.
During a fungal infection in the absence of hypoxia, HIF-1alpha degradation will lead to increasing levels of hydroxyproline after it is ubiquitinated and degraded. This leads to an excess of hydroxyproline that must be metabolized as it is unable to be used again to synthesize proteins. This can lead to high oxalate formation as well as glycolate formation. This process can also happen in individuals with sleep apnea that can maintain normal oxygen levels while awake. These individuals cycle between low oxalate and glycolate states to high oxalate and glycolate states. In fact, Zoey, my daughter with sleep apnea, consistently has a headache and nausea every afternoon no matter what foods I feed her. She wakes up a bit sleepy, has a pretty good morning, and then goes downhill by the afternoon and requires Zofran for nausea and lays on the couch completely incapacitated. I believe this could be due to her body catching up with HIF-1alpha degradation with the resulting production of glycolate and oxalate. It appears she isn’t alone. Hydroxyproline degradation has been found to be a contributor to oxalate formation in all three types of primary hyperoxaluria. Perhaps the source of the excess hydroxyproline is overactivation of the HIF-1alpha pathway. Figure 4 shows that hydroxyproline is metabolized in the mitochondria to glyoxylate, glycolate, and glycine, and oxalate.
EVIDENCE THAT THIS IS TRULY HAPPENING? ORGANIC ACID TESTS FOUND IN VIDEO BELOW.
The video below goes through individual labs, and, in particular, shows one client who ate carnivore diet for about one week before her second organic acid test. This diet completely resolved her hyperoxaluria and high glycolate levels! This particular client’s information is at about 27 minutes and shows that changing to a very low carbohydrate diet alleviating her hyperoxaluria.
SOLUTIONS TO HIF-1ALPHA INDUCED HYPEROXALURIA?
Honestly, I have thought long and hard about this. My daughter Zoey has moderate to severe obstructive sleep apnea causing chronic hypoxia and induction of HIF-1alpha. I explored the possibility of inhibiting the gene transcription for HIF-1alpha with known inhibitors. I think for my own daughter, Zoey, I will not be trying to inhibit HIF-1alpha through use of known inhibitors. I believe that this could be counterproductive if she is fighting a fungal or bacterial infection.
However, I do plan on controlling her sleep apnea issues. She wears CPAP at night but is quite non-compliant with it. Her sleep medicine doctor is willing to try a little bit of oxygen, but we are also doing an evaluation with an ENT to make sure that her sinus passages are normal as well as an evaluation with neurosurgery because she has an alteration in her C1 vertebrae that could be causing the hypotonic sleep apnea. I highly recommend if someone has an underlying apnea issue, to have a CT scan of the sinus and C1 vertebrae. These areas, if altered, can be a major source of hypoxia.
Something else to consider is that fighting off pathogens causing high levels of reactive oxygen species (ROS) through NOX, but also sleep apnea itself induces the activity of an enzyme, xanthine oxidase, that also creates reactive oxygen species which inhibits proline hydroxylation of the pro-oxidative stress, HIF-1alpha. This keeps HIF-1alpha in an active state causing massive oxidative stress through NOX and down regulation of antioxidant HIF-2alpha. This type of high activity of NOX is pathogenic and can lead to excessive ROS and disease. How would someone know if they have elevated XO activity? They could monitor uric acid urine levels while eating carbohydrates and on a low purine diet (as purines will definitely increase uric acid alone). Xanthine oxidase converts xanthine to uric acid. Inhibitors of xanthine oxidase might be beneficial for people with chronic hypoxia to lower the overall oxidative stress on the body. Although drugs are available for this purpose, you might choose natural inhibitors of xanthine oxidase with your own healthcare provider.
Another goal that I have for my daughter, Zoey, is to avoid fungal and bacterial infections. This, of course, takes a bit more work from a nutrition standpoint. Definitely seek out a practitioner who understands the importance of nutrition for immune health as avoiding chronic fungal or bacterial infections is likely the key to prevention of extreme alterations in metabolism by HIF-1alpha expression. However, I do think having normal gene transcription for HIF-1alpha is crucial to mount a defense against pathogens.
Something I definitely don’t recommend if you have an active bacterial or fungal infection is a carnivore or keto diet long term. These diets may help with working around the block in metabolism at PDHC by lowering total glucose availability, but if there is truly an infection that needs to be resolved, a carbohydrate free diet will starve immune cells of very much needed glucose. Glucose is needed to fuel the HIF-1alpha upregulated pentose phosphate pathway to make NADPH which is used by NADPH dependent oxidase (NOX) to produce superoxide for killing pathogens. When I noticed that someone I am caring for has high microbial or fungal markers on their OAT, even though they might feel better on a keto diet because it lowers total pyruvate levels and decreases both glycolate and oxalate production, I think it would be better to continue to eat a well-balanced diet to fuel the immune system. They might realize that eating about 100 grams of carbohydrate per day is a happy medium where they don’t feel sick from glycolate and oxalate, but they are still able to maintain immune function. This would be per person of course.
Overall, I think discovery of this possible mechanism of increased oxalate and glycolate formation due to a block at PDHC from HIF-1alpha is going to change my daughter’s life. We have a new focus on how to promote her health and well being. The mystery of hyperoxaluria is not so much a mystery afterall.
The importance of ALDH7A1 competition in anhydroretinol formation
ALDH7A1 is an enzyme that moonlights throughout the cell and goes where it is needed based on cellular metabolism. In oxygen deprivation it becomes a regulator of cellular energy homeostasis. This enzyme also is tied up in lipid peroxidation detox, histamine metabolism, and betaine production in the setting of a low betaine diet (Gluten free diets are a huge cause of burden on ALDH7A1). Betaine is the cofactor for BHMT that runs methionine salvage pathways in the liver, kidneys, and small parts of the brain (this is found in a model of MS) while under conditions of low 5-methylfolate production or B12 deficiency or during a high nitric oxide state which inhibits the enzyme methionine synthase.
If ALDH7A1 is not doing lysine metabolism this results in an increase in P6C and inactivation of P5P (vitamin B6). This can lead to insufficiency of B6 and the body will have to choose where to use it. One problem with low B6 levels is that this leads to poor denovo NAD production. NAD is a cofactor needed for ADH that is required to deal with the tiny bit of alcohol produced during digestion (3 grams – about 1/2 shot glass) and also the alcohol being made from gut dysbiosis (alcohol producers such as candida, aspergillus, s. boulardii. s cerevisiae, e.coli, clostridia).
If you can minimize lipid peroxidation, the need to make betaine, or consume enough betaine, and limit histamine needing ALDH7A1, then this will allow normal lysine metabolism and normal de novo NAD metabolism and then we are no longer reluctant alcoholics.
This requires focusing on each person’s ability to deal with oxidative stress as well as their methylation pathway. The innate immune system plays a role as well because activated macrophages cause increased iNOS expression which results in increased nitric oxide formation and inhibition of methionine synthase. Thus, chronic bacterial infections will trigger a major downstream effect resulting in a risk factor for making anhydroretinol.
Anhydroretinol obliterates f-actin which is a cytoskeletal protein. This scaffold controls the calcium exporter PMCA that is found in all cells as a housekeeper to regulate calcium. Actin is found in the G-Actin state or the F-actin state or an in-between state called an oligomer. When it’s an oligomer it turns on calcium export to bring the cells back to a normal intracellular calcium level, so it doesn’t go through apoptosis. When it grows into F-actin, PMCA is turned off and calcium accumulates. It cycles back and forth between the long F-actin chains and oligomers, but being destroyed down to G-Actin by anhydroretinol would in theory cause loss of PMCA function. If anhydroretinol stays around too long, then apoptosis occurs due to loss of cytoskeleton and hypercalcemia.
If cellular levels of anhydroretinol are not to the point of causing apoptosis, the resulting excess calcium in cells will cause overactivation of calmodulin. Calmodulin is what causes the Stra6 pore to prefer to stay open, but instead of doing a normal influx and efflux, when calcium is high it lets retinol leave the cell and doesn’t let retinol in cells as much. This also occurs in the setting of magnesium deficiency because calmodulin overactivation is controlled by an EF-hand on calmodulin that requires magnesium. If calmodulin is overactivated, this causes low retinol uptake and thus cellular retinoic acid deficiency, but high serum vitamin A levels due to efflux back onto RBP4 which we classically see as vitamin A toxicity. What I have found is that vitamin A toxicity is actually both a toxicity and deficiency at the same time.
The provision of “fresh” retinol in a cell from postprandial chylomicrons could save the day because it has been shown to stabilize F-actin in a model where anhydroretinol destroys it. Dietary retinol could work as long as alcohol is dealt with properly in the gut, and the person does not make anhydroretinol in their gut. Anhydroretinol can be made into rehydroretinol when cellular alcohol levels are low, but it is only about 7% of the activity of the original retinol molecule, and so whether or not it also can act to stabilize F-actin is questionable.
One more interesting aspect of F-actin is that it is the scaffold for KEAP1 which regulates NFR2 activation. If F-actin is destroyed by anhydroretinol, this causes alteration in KEAP1 scaffolding and this could lead to dysregulation of NRF2. I’m finding that mostly it leads to overactivation of NRF2 which causes hyperkeratosis as NRF2 not only turns on genes for dealing with oxidative stress, but also turns on keratin producing genes. I believe this is the cause of hyperkeratosis. My vitamin A toxic client experience shows they are all struggling from hyperkeratosis and keratosis pilaris.
How do we keep anhydroretinol in control? We control alcohol levels.
What factors deal with alcohol. 1. NAD (The biggest concern is de novo production via kynurenine pathway or maximize recycling of cytosolic NAD via avoidance of high oxalate diet if needed.) 2. SULT (acts as a backup buffer) (SULT1A1 in human intestines) 3. Vitamin E (can help restore NAD recycling and prevent lipid peroxidation)
4. CYP2E1 (although this is the last resort because it causes oxidative stress)
What can lower #1 NAD? 1. Functional B6 deficiency from ALDH7A1 competition leads to low NAD production 2. Cytosolic recycling of NAD is inhibited by oxalate inhibition of LDH 3. Pyroluria 4. High alcohol intake
5. Gut dysbiosis
What can lower #2 SULT? 1. SUOX issues (Moco, B2, B6) 2. Arsenic, chlorate, and perchlorate inhibit PAPS synthase 3. Salicylates inhibiting SULT 4. Quercetin inhibiting SULT 5. Excess H202 causing sulfite radicals instead of sulfate to produce which causes lower levels of PAPS
What can cause issues with #3 vitamin E? 1. Low E diet due to eliminating too many foods 2. Excess oxidative stress causing increasing vitamin E needs
What can cause issues with #4 CYP2E1?
Inhibitors (which could be good due to CYP2E1 causes more oxidative stress, but if #1-3 is down, CYP2E1 may be the only way to deal with alcohol in the liver). Inhibitors of CYP2E1 include – quercetin, cannabidiol, niacin, niacinamide, menadione
Calcium excess in cells has side effects (here are just some of them):
1. Seizures
2. Mast cell activation
3. Decreased aromatase activity leading to low estrogen and slow PEMT needed to make PC for making CDP-Choline for plasmalogens (leads to membrane instability)
We need to be making MoCo to have back up enzymes for metabolizing retinol and retinaldehyde. It requires several cofactors to be made.
Lack of sulfate causing damage to immune cells in the gut because of anhydroretinol toxicity?
Here is where SIBO comes in…
